Glucagon-Like Peptide 1 Receptor Agonist Usage in Type 2 Diabetes in Primary Care for the UK and Beyond: A Narrative Review Kevin FernandoStephen C. BainDipesh C. Patel Review Open access 26 July 2021 Pages: 2267 - 2288
Telemonitoring, Telemedicine and Time in Range During the Pandemic: Paradigm Change for Diabetes Risk Management in the Post-COVID Future Thomas DanneCatarina LimbertAlexander Seibold Review Open access 02 August 2021 Pages: 2289 - 2310
The Challenge of Sustainable Access to Telemonitoring Tools for People with Diabetes in Europe: Lessons from COVID-19 and Beyond Pratik ChoudharyVirginia BellidoFinn Børlum Kristensen Review Open access 14 August 2021 Pages: 2311 - 2327
Cost Analysis of FreeStyle Libre® 2 System in Type 2 Diabetes Mellitus Population Itziar OyagüezFernando Gómez-PeraltaAntonio Pérez Original Research Open access 04 May 2021 Pages: 2329 - 2342
Factors Associated With Treatment Adherence and Satisfaction in Type 2 Diabetes Management in Japan: Results From a Web-Based Questionnaire Survey Ryo SuzukiShun SaitaMasato Odawara Original Research Open access 20 July 2021 Pages: 2343 - 2358
Effect of Baseline Characteristics on Hypoglycaemia Risk with Insulin Glargine 100 U/mL: Post Hoc Analysis of the BEYOND 7 Study Hailong WanBinhong WenLinong Ji Original Research Open access 21 July 2021 Pages: 2359 - 2369
Impact of Socioeconomic Factors and Gender on Refill Adherence and Persistence to Lipid-Lowering Therapy in Type 1 Diabetes Christel HeroSofia Axia KarlssonKatarina Eeg-Olofsson Original Research Open access 22 July 2021 Pages: 2371 - 2386
Patient Perceptions of and Preferences Between Characteristics of Injectable Diabetes Treatments Kristina S. BoyeJessica B. JordanLouis S. Matza Original Research Open access 23 July 2021 Pages: 2387 - 2403
A Real-World, Prospective, Non-interventional Study of Adults with T2D Switching to IDegAsp from Glargine U100 or U300 in Japan Fumika ShigiyamaLei LiuTakahisa Hirose Original Research Open access 25 July 2021 Pages: 2405 - 2421
Better Islet Function and Cardiovascular Autonomic Function in Chinese Type 2 Diabetic Patients with Pure Small Fiber Neuropathy than with Mixed Neuropathy Chenxi LiWeimin WangDalong Zhu Original Research Open access 02 August 2021 Pages: 2423 - 2436
Shift of Glucose Peak Time During Oral Glucose Tolerance Test is Associated with Changes in Insulin Secretion and Insulin Sensitivity After Therapy with Antidiabetic Drugs in Patients with Type 2 Diabetes Yanqiu JiangShiwei CuiXinlei Wang Original Research Open access 03 August 2021 Pages: 2437 - 2450
Insulin Injection Knowledge, Attitudes, and Practices of Nurses in China: A Cross-Sectional Nationwide Study Xinjuan WuFang ZhaoCaihong Li Original Research Open access 04 August 2021 Pages: 2451 - 2469
Long-term Efficacy and Safety of Ultra Rapid Lispro in Japanese Patients With Type 1 Diabetes: Subpopulation Analysis of the 52-Week PRONTO-T1D Study Junnosuke MiuraHiroshi NishiyamaMakoto Imori Original Research Open access 04 August 2021 Pages: 2471 - 2484
Effect of Mineralocorticoid Receptor Antagonism and ACE Inhibition on Angiotensin Profiles in Diabetic Kidney Disease: An Exploratory Study Johannes J. KovarikChristopher C. KalteneckerMarcus D. Säemann Original Research Open access 05 August 2021 Pages: 2485 - 2498
The Influence of Tofogliflozin on Treatment-Related Quality of Life in Patients with Type 2 Diabetes Mellitus Naoto KatakamiTomoya Mitathe UTOPIA study investigators Original Research Open access 06 August 2021 Pages: 2499 - 2515
Effectiveness of IGlarLixi, a Fixed-Ratio Combination of Insulin Glargine 100 U/mL and Lixisenatide, in People with Type 2 Diabetes János Tibor KisGábor NagyGábor Kovacs Original Research Open access 06 August 2021 Pages: 2517 - 2529
Assessment of Patient Satisfaction with On-Site Point-of-Care Hemoglobin A1c Testing: An Observational Study Ayman A. Al HayekAbdulghani H. Al-SaeedMohamed A. Al Dawish Original Research Open access 07 August 2021 Pages: 2531 - 2544
Efficacy of a New Protocol of Premixed 70/30 Human Insulin in Haitian Youth with Diabetes Eddy Jean-BaptistePhilippe LarcoNancy Charles Larco Original Research Open access 11 August 2021 Pages: 2545 - 2556
The Durability of an Intensive, Structured Education-Based Rehabilitation Protocol for Best Insulin Injection Practice: The ISTERP-2 Study Sandro GentileGiuseppina GuarinoNefrocenter Research and Nyx Start-Up Study Group Original Research Open access 12 August 2021 Pages: 2557 - 2569
Does Current Diabetes Technology Improve Metabolic Control? A Cross-Sectional Study on the Use of Insulin Pumps and Continuous Glucose Monitoring Devices in a Nationwide Pediatric Population Heiko BratkeHanna D. MargeirsdottirTorild Skrivarhaug Original Research Open access 13 August 2021 Pages: 2571 - 2583
Effects of Moderate-Intensity Aerobic Exercise on Blood Glucose Levels and Pregnancy Outcomes in Patients With Gestational Diabetes Mellitus: A Randomized Controlled Trial Xie YapingZhao HuifenWu Jingjing Original Research Open access 13 August 2021 Pages: 2585 - 2598
Absence of QTc Prolongation with Sodium N-(8-[2-Hydroxybenzoyl] Amino) Caprylate (SNAC), an Absorption Enhancer Co-Formulated with the GLP-1 Analogue Semaglutide for Oral Administration Charlotte GranhallTine A. BækdalMette Thomsen Brief Report Open access 28 July 2021 Pages: 2599 - 2610
Cyclothymic Temperament is Associated with Poor Medication Adherence and Disordered Eating in Type 2 Diabetes Patients: A Case–Control Study Tetsuya YamamotoKenichi SakuraiRyoichi Ishibashi Brief Report Open access 31 July 2021 Pages: 2611 - 2624
Correction to: One Year of Dapaglifozin Add-On Therapy Ameliorates Surrogate Indexes of Insulin Resistance and Adiposity in Patients with Type 2 Diabetes Mellitus Stefano RadelliniEnrica VigneriCarla Giordano Correction Open access 27 July 2021 Pages: 2625 - 2625
Correction to: Individualizing Time-in-Range Goals in Management of Diabetes Mellitus and Role of Insulin: Clinical Insights From a Multinational Panel Sanjay KalraShehla ShaikhDiana A. Nkansah Correction Open access 06 August 2021 Pages: 2627 - 2629